Pub. Date : 2011 Jan 15
PMID : 21220945
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Therapies that target BCR-ABL in chronic myeloid leukemia, including imatinib, dasatinib and nilotinib, have dramatically improved patient outcome. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |
| 2 | In vitro, dasatinib and nilotinib inhibit most imatinib-resistant BCR-ABL mutations, except for T315I. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |